News | January 07, 2015

RSNA Research Demonstrates Benefit of Volpara Volumetric Breast Analytics for Dense Breast Assessment

Six abstracts cover topics including patient-specific dose, applied pressure

January 7, 2015 — The value of volumetric breast imaging data to provide critical insight for optimal breast imaging quality and workflow was the focus of numerous abstracts accepted for presentation at the 100th Annual Meeting of the Radiology Society of North America (RSNA), November 30-December 5, 2014. 

According to Volpara Solutions, six abstracts highlight the use of quantitative breast imaging software tools to provide breast imaging and analytics data. Presented data types including volumetric density, patient-specific dose, applied pressure and other factors designed to maintain accuracy and consistent quality in breast screening using digital mammography and digital breast tomosynthesis.

In the scientific exhibit, “Can we use the manufacturer reported mammography dose to inform patients?” (BRS263), researchers from Elizabeth Wende Breast Center reviewed manufacturer-reported mean-glandular dose (MGD) for 30 women who had undergone sequential screening mammograms on a mix of three manufacturers’ systems. The manufacturer-reported MGD varied considerably sequential mammograms and between manufacturers, with changes ranging from -2.87 to +4.31 mGy.  Additionally, since the algorithms used by manufacturers vary, the estimations are not easily compared.

This is consistent with other research, which has demonstrated that mammography units routinely under- or overestimate dose because they do not include the patient’s specific volumetric breast density in the estimation. In another abstract examining patient dose in mammography, “System-wide monitoring of mammographic radiation dose for quality assurance”, researchers from Weinstein Imaging used VolparaAnalytics on more than 11,000 images to compare manufacturer-reported MGD to a patient-specific estimate. Automated stratification of the data by mammography unit suggested that one vendor underestimated MGD compared to the patient-specific dose calculations, despite similar breast density characteristics of the populations. The abstract concludes that for more accurate reporting of MGD, it is essential that a standardized method be used across all manufacturers’ systems.

"At Weinstein Imaging, we want to ensure our patients are safe and informed during screening. Part of that includes monitoring and recording patient dose. Volpara enables true comparison of dose across machines so that we can spot issues early and truly keep women safe and informed," said Marcela Böhm-Vélez, practicing radiologist and president of Weinstein Imaging.

Accurate breast density estimation is important for breast cancer risk assessment and guiding personalized breast screening recommendations. In the presentation, “Fully automated volumetric breast density estimation from digital breast tomosynthesis images: Multimodality comparison with digital mammography and breast MRI”, researchers from the University of Pennsylvania reviewed results of a study to evaluate the feasibility of automated volumetric breast density for breast tomosynthesis and compared the results to digital mammography and breast magnetic resonance imaging (MRI). The abstract concludes that volumetric breast density estimates from breast tomosynthesis data sets were highly correlated to density estimates from digital mammography and MRI, and hold the potential for more accurate density assessments and more accurate measures of breast cancer risk. 

In addition, the “Breast Imaging Breast Density & Risk Assessment” session included three presentations that featured VolparaDensity: ”Automated volumetric breast density and risk of cancer stratified by pathological attributes,” “Comparing breast density measurement techniques in screening digital mammography” and  “The diagnostic effect of digital breast tomosynthesis in relation to visually assessed and automated volumetric breast density.”  The role of volumetric density in adjunctive imaging for women with dense breasts was the topics of numerous presentations.

For more information: www.volparasolutions.com

Related Content

Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Sponsored Content | Videos | Breast Imaging | January 11, 2019
Supplemental screening with ABUS helps personalize breast care for women with dense breasts and offers advanced...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...
Opto-Acoustic Imaging Helps Differentiate Breast Cancer Molecular Subtypes
News | Ultrasound Women's Health | December 20, 2018
Seno Medical Instruments Inc. (Seno Medical) reported results of a study demonstrating that morphologic and functional...
Densitas Enters Platform Partnership With Blackford
News | Breast Density | December 19, 2018
Breast imaging analytics company Densitas Inc. announced the signing of a new Alliance Partner Agreement with Blackford...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RSNA Study Shows Real-Time Indicator Improves Mammographic Compression
News | Mammography | December 12, 2018
Sigmascreening recently announced that more than 100,000 women have had mammography exams with the Sensitive Sigma...